Dubai Investments' subsidiary, Globalpharma, inks a Memorandum of Understanding with Angola's Ministry of Health

In a significant move to enhance healthcare self-sufficiency in Angola, Dubai Investments, through its wholly owned subsidiary Globalpharma, has signed a Memorandum of Understanding (MoU) with Angola's Ministry of Health. This partnership is set to drive local production of medicines in Angola.

The MoU aims to establish a pharmaceutical manufacturing facility in DIP Angola, a first-of-its-kind integrated economic zone in the country. Dubai Investments has been steadily expanding its footprint in Angola over the last two years, with this initiative being a testament to their commitment to contributing to Africa's industrialization.

Globalpharma, the UAE's leading pharmaceutical manufacturer, boasts cGMP-certified manufacturing facilities approved by health authorities across the GCC, Levant, Africa, and CIS regions. With over two decades of experience in producing high-quality generic and branded medicines across key therapeutic areas, Globalpharma is well-equipped to spearhead this venture.

The partnership is expected to reduce Angola's reliance on imported medical products, a key milestone in enhancing healthcare self-sufficiency in the country. The Ministry of Health will coordinate with relevant government bodies to expedite the issuance of licenses, permits, and regulatory approvals for DIP Angola. Moreover, the Ministry has committed to supporting and facilitating the successful implementation of DIP Angola's projects.

The MoU also includes a commitment by the Ministry of Health to facilitate access to available tax incentives, exemptions, and investment benefits for DIP Angola, in accordance with national laws and investment promotion regulations. This move is expected to create hundreds of jobs in Angola.

The MoU signing is a key milestone in strengthening bilateral relations between the UAE and Angola. Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, and Dr. Nídia da Silva Jorge Saiundo, representing their respective entities, signed the MoU.

This partnership is expected to play a significant role in Angola's journey towards self-sufficiency in healthcare, contributing to a more robust and resilient healthcare system for the nation. The exact date of the signing of the MoU is not specified, but the partnership marks an exciting new chapter in the collaboration between the UAE and Angola.

Dubai Investments' subsidiary, Globalpharma, inks a Memorandum of Understanding with Angola's Ministry of Health